Skip to main content
. 2019 Apr 1;2(2):e201800195. doi: 10.26508/lsa.201800195

Table 1.

Engraftment of human leukocytes in NSG mice expressing hIL-7 and/or hIL-15.

Mouse ID CB ID Strain Weeka Spleen, % PB, %
hCD45+b CD56+ CD3+ CD19+ CD33+ hCD45+b CD56+ CD3+ CD19+ CD33+
IL7x15#1 CB#1 hIL-7xhIL-15 KI 15 46.6 35.3 11.4 19.2 15.3 15.0 60.4 6.5 2.4 6.1
IL7x15#2 CB#1 hIL-7xhIL-15 KI 18 35.8 38.6 1.3 11.1 10.4 30.5 68.5 1.3 11.1 10.4
IL7x15#3 CB#2 hIL-7xhIL-15 KI 10 98.1 13.0 0.1 78.8 3.1 93.6 38.5 0.3 42.2 7.8
IL7x15#4 CB#2 hIL-7xhIL-15 KI 16 92.7 3.8 23.5 57.8 5.7 95.9 19.2 37.4 15.4 10.1
IL7x15#5 CB#3 hIL-7xhIL-15 KI 13 76.0 18.7 0.2 67.1 3.5 22.3 70.6 0.1 11.7 9.4
IL7x15#6 CB#4 hIL-7xhIL-15 KI 19 77.7 22.1 2.5 49.0 4.1 30.4 37.7 2.5 26.7 4.9
IL7x15#7 CB#4 hIL-7xhIL-15 KI 22 66.8 26.0 26.8 26.5 3.6 18.8 38.3 33.1 21.0 1.4
IL7x15#8 CB#4 hIL-7xhIL-15 KI 23 64.4 16.2 10.1 16.2 6.6 15.7 6.0 18.2 24.3 3.1
IL7x15#9 CB#5 hIL-7xhIL-15 KI 13 80.6 36.6 1.7 40.8 8.2 49.2 47.2 1.2 19.3 20.0
IL7x15#10 CB#6 hIL-7xhIL-15 KI 19 65.9 52.9 1.0 17.3 14.5 30.8 64.9 0.6 6.9 8.3
IL7x15#11 CB#7 hIL-7xhIL-15 KI 16 97.0 1.2 74.6 15.4 3.4 98.7 9.8 69.2 1.2 1.0
IL7x15#12 CB#7 hIL-7xhIL-15 KI 17 92.3 2.6 72.5 17.6 2.6 85.8 14.3 67.6 3.6 1.8
IL7x15#13 CB#8 hIL-7xhIL-15 KI 13 51.1 21.7 0.9 60.0 11.5 4.8 37.6 0.7 13.3 22.6
IL7x15#14 CB#9 hIL-7xhIL-15 KI 20 28.8 56.0 2.5 11.5 9.2 11.6 70.2 1.4 7.6 10.5
IL7x15#15 CB#10 hIL-7xhIL-15 KI 11 78.7 9.4 0.4 76.1 5.1 77.1 25.2 0.3 34.7 27.9
IL7x15#16 CB#11 hIL-7xhIL-15 KI 15 58.7 72.8 1.1 12.9 6.7 7.4 68.8 0.0 8.5 15.3
IL7x15#17 CB#12 hIL-7xhIL-15 KI 15 74.1 54.1 0.8 27.8 8.1 20.1 55.4 0.9 20.8 2.0
IL7x15#18 CB#13 hIL-7xhIL-15 KI 8 68.9 25.6 0.0 54.1 7.8 7.7 24.6 0.0 29.1 33.0
IL7x15#19 CB#14 hIL-7xhIL-15 KI 16 23.9 87.5 0.5 7.6 1.5 2.2 82.8 0.8 5.5 3.1
IL7x15#20 CB#15 hIL-7xhIL-15 KI 9 56.9 31.3 0.0 32.3 22.5 35.9 60.0 0.1 8.2 18.2
IL7x15#21 CB#16 hIL-7xhIL-15 KI 11 46.5 61.5 1.2 24.1 3.6 31.2 70.7 1.2 12.4 4.9
IL7x15#22 CB#17 hIL-7xhIL-15 KI 10 90.4 8.6 0.4 72.5 8.6 75.6 29.8 0.8 35.6 28.3
IL7x15#23 CB#17 hIL-7xhIL-15 KI 11 77.3 7.7 0.5 77.3 10.1 61.7 13.8 0.8 49.2 27.5
IL7KI#1 CB#13 hIL-7 KI 18 99.5 0.4 1.5 11.5 83.9 97.2 1.1 4.4 4.6 85.4
IL7KI#2 CB#13 hIL-7 KI 19 87.9 5.0 10.7 36.6 37.9 83.3 11.7 20.0 23.4 27.8
IL7KI#3 CB#14 hIL-7 KI 21 90.5 3.1 10.3 25.9 57.1 59.9 4.5 18.4 40.9 25.6
IL7KI#4 CB#14 hIL-7 KI 19 93.7 1.9 10.4 49.4 34.5 98.4 1.9 63.4 14.1 15.0
IL7TG#5 CB#15 hIL-7 Tg 16 97.8 1.2 8.0 58.6 22.2 92.3 1.7 32.1 25.2 26.2
IL7TG#6 CB#16 hIL-7 Tg 12 81.0 0.6 2.5 73.9 8.5 93.1 0.7 2.2 73.9 14.4
IL7TG#7 CB#17 hIL-7 Tg 24 95.6 0.3 2.1 11.3 84.9 81.9 0.3 0.2 2.8 95.4
NSG#1 CB#1 NSG 20 79.8 0.3 48.6 40.1 1.6 43.6 0.2 91.1 5.0 0.7
NSG#2 CB#2 NSG 17 78.1 0.2 77.5 19.1 1.4 68.5 0.2 96.9 1.0 0.2
NSG#3 CB#2 NSG 18 85.9 0.6 14.8 74.5 3.9 37.8 0.6 50.8 28.9 11.4
NSG#4 CB#3 NSG 18 90.3 1.2 7.5 76.7 6.4 59.8 1.2 15.2 51.6 17.2
NSG#5 CB#3 NSG 19 92.4 1.2 20.5 72.4 3.5 81.5 2.5 44.0 44.3 3.6
NSG#6 CB#3 NSG 20 91.7 1.1 10.8 72.6 5.4 68.1 1.0 28.2 36.7 22.4
NSG#7 CB#5 NSG 18 71.6 0.9 52.4 47.9 1.2 37.4 0.8 74.5 20.5 1.7
NSG#8 CB#5 NSG 19 90.2 0.2 77.6 24.0 0.9 79.9 0.6 89.2 7.0 2.3
NSG#9 CB#7 NSG 17 98.8 0.1 64.8 30.9 1.2 97.9 0.6 83.3 10.6 0.3
NSG#10 CB#8 NSG 19 88.6 2.3 40.9 48.2 6.4 36.1 1.9 46.1 42.9 4.9
NSG#11 CB#8 NSG 19 88.5 0.7 35.3 58.1 4.8 39.4 0.3 46.6 48.7 2.3
NSG#12 CB#10 NSG 20 98.6 0.1 60.2 32.1 0.8 97.0 0.5 85.5 7.7 1.3
NSG#13 CB#10 NSG 20 93.9 0.8 56.7 38.7 3.2 79.8 2.3 78.8 7.2 5.6
NSG#14 CB#12 NSG 19 84.4 1.0 37.8 55.8 3.3 56.7 0.9 54.1 41.7 1.6
NSG#15 CB#12 NSG 21 85.1 0.7 40.4 53.1 2.7 49.9 0.7 56.0 34.7 3.8
NSG#16 CB#13 NSG 22 95.9 0.2 75.9 13.4 2.2 97.4 0.4 90.0 2.2 3.6
NSG#17 CB#13 NSG 23 78.5 1.8 61.8 27.1 3.9 28.5 4.3 64.8 18.9 3.5
NSG#18 CB#14 NSG 21 82.1 0.4 38.8 56.4 2.3 31.5 0.2 63.3 29.1 3.4
NSG#19 CB#18 NSG 17 93.7 0.7 55.3 38.9 1.5 62.0 1.0 75.8 18.5 1.8
NSG#20 CB#18 NSG 19 83.3 0.6 49.7 43.9 0.9 66.1 0.6 88.9 6.3 0.1
NSG#21 CB#19 NSG 20 99.7 0.3 83.0 13.4 1.4 99.0 0.5 90.9 4.9 1.5
NSG#22 CB#18 NSG 19 89.9 1.7 54.5 36.5 2.1 64.7 1.4 76.5 18.1 1.4
NSG#23 CB#18 NSG 19 93.6 0.5 16.0 79.6 1.0 81.7 0.5 20.2 76.7 0.2
NSG#24 CB#19 NSG 17 87.0 2.0 46.4 45.1 3.3 42.8 7.0 65.9 14.1 2.8
a

Number of weeks after CB transplantation when euthanized are shown.

b

Frequencies of human CD45+ cells in total leukocytes including human and mouse CD45+ cells.